Communiqués Evogene Ltd.

Actions

EVGN

IL0011050551

Marché Fermé - TEL AVIV STOCK EXCHANGE Autres places de cotation 16:24:19 16/07/2024			Varia. 5j.	Varia. 1 janv.
235,3 ^ILa	+1,60 %		-1,42 %	-21,51 %

20/06	Nir Arbel quitte son poste de Chief Product Officer d'Evogene Ltd	CI
23/05	Evogene Ltd. fournit des prévisions de revenus pour l'année 2024	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Lavie Bio Announces Commercial Expansion of Yalos(TM) to Winter Wheat - Evogene	02/07	AQ
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat	02/07	PR
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country - Evogene	26/06	AQ
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country	25/06	PR
Evogene : Other Report or Announcement	20/06	PU
Evogene : Other Report or Announcement	17/06	PU
Evogene : Lavie Bio Company Presentation	09/06	PU
Evogene : Immediate Report of Meeting	06/06	PU
Evogene : Corporate Presentation	29/05	PU
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma - Evogene	24/05	AQ
Evogene : Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma	23/05	PU
Evogene Reports First Quarter 2024 Financial Results - Evogene	23/05	AQ
Evogene : Q1 2024 Consolidated Financial Statements	23/05	PU
Evogene: Q1 Earnings Snapshot	23/05	AQ
Evogene Reports First Quarter 2024 Financial Results	23/05	PR
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds - Evogene	22/05	AQ
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds	21/05	PR
Evogene Schedules First Quarter 2024 Financial Results Release - Evogene	09/05	AQ
Schedules First Quarter 2024 Financial Results Release on May 23, 2024,conference call to discuss the results at 9:00 AM EST	09/05	PU
Evogene : 2024 Annual General Meeting of Shareholders	02/05	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Evogene Ltd.

Actions

EVGN

IL0011050551

Communiqués

Filtres